Waverton Investment Management LTD Pfizer Inc Transaction History

Waverton Investment Management LTD

$5.42 Billion
Q3 2024

A detailed history of Waverton Investment Management LTD transactions in Pfizer Inc stock. As of the latest transaction made, Waverton Investment Management LTD holds 33,944 shares of PFE stock, worth $894,763. This represents 0.02% of its overall portfolio holdings.

Number of Shares

33,944

Previous 43,624 22.19%

Holding current value

$894,763

Previous $1.22 Million 19.51%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$27.7 - $31.39 $268,136 - $303,855	-9,680 Reduced 22.19%	33,944 $982,000
Q2 2024 Aug 05, 2024	SELL	$25.26 - $29.6 $22,734 - $26,640	-900 Reduced 2.02%	43,624 $1.22 Million
Q1 2024 May 08, 2024	BUY	$25.89 - $29.73 $569,580 - $654,060	22,000 Added 97.67%	44,524 $1.24 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $428,532 - $556,616	-16,400 Reduced 42.13%	22,524 $648,000
Q2 2023 Aug 02, 2023	SELL	$36.12 - $41.79 $49,014 - $56,709	-1,357 Reduced 3.37%	38,924 $1.43 Million
Q1 2023 Apr 27, 2023	SELL	$39.39 - $51.28 $132,153 - $172,044	-3,355 Reduced 7.69%	40,281 $1.64 Million
Q4 2022 Feb 02, 2023	SELL	$41.75 - $54.5 $41,750 - $54,500	-1,000 Reduced 2.24%	43,636 $2.24 Million
Q3 2022 Oct 19, 2022	SELL	$43.76 - $53.42 $214,424 - $261,758	-4,900 Reduced 9.89%	44,636 $1.95 Million
Q2 2022 Jul 13, 2022	SELL	$46.53 - $55.17 $62,582 - $74,203	-1,345 Reduced 2.64%	49,536 $2.6 Million
Q1 2022 Apr 26, 2022	SELL	$45.75 - $56.69 $226,462 - $280,615	-4,950 Reduced 8.87%	50,881 $2.63 Million
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $95,036 - $140,875	-2,300 Reduced 3.96%	55,831 $3.3 Million
Q2 2021 Aug 02, 2021	SELL	$35.91 - $40.68 $397,703 - $450,531	-11,075 Reduced 16.0%	58,131 $2.28 Million
Q1 2021 Apr 27, 2021	SELL	$33.49 - $37.77 $452,115 - $509,895	-13,500 Reduced 16.32%	69,206 $2.51 Million
Q4 2020 Jan 22, 2021	SELL	$33.47 - $42.56 $438,457 - $557,536	-13,100 Reduced 13.67%	82,706 $3.04 Million
Q3 2020 Oct 28, 2020	SELL	$31.75 - $37.25 $176,212 - $206,737	-5,550 Reduced 5.48%	95,806 $3.52 Million
Q2 2020 Jul 16, 2020	SELL	$30.12 - $36.54 $31,324 - $38,001	-1,040 Reduced 1.02%	101,356 $3.31 Million
Q1 2020 Apr 30, 2020	BUY	$27.03 - $38.62 $47,032 - $67,198	1,740 Added 1.73%	102,396 $3.34 Million
Q4 2019 Jan 23, 2020	BUY	$32.92 - $37.36 $3.31 Million - $3.76 Million	100,656 New	100,656 $3.94 Million
Q4 2019 Jan 22, 2020	SELL	$32.92 - $37.36 $3.86 Million - $4.38 Million	-117,156 Closed	0 $0
Q3 2019 Oct 29, 2019	SELL	$32.49 - $42.13 $184,608 - $239,382	-5,682 Reduced 4.63%	117,156 $4.21 Million
Q2 2019 Jul 17, 2019	SELL	$36.98 - $41.52 $137,491 - $154,371	-3,718 Reduced 2.94%	122,838 $5.32 Million
Q1 2019 Apr 18, 2019	SELL	$37.5 - $41.2 $737,925 - $810,733	-19,678 Reduced 13.46%	126,556 $5.38 Million
Q4 2018 Jan 14, 2019	SELL	$38.47 - $43.86 $259,672 - $296,055	-6,750 Reduced 4.41%	146,234 $6.38 Million
Q3 2018 Oct 04, 2018	SELL	$34.47 - $41.81 $111,165 - $134,837	-3,225 Reduced 2.06%	152,984 $6.74 Million
Q2 2018 Aug 22, 2018	BUY	$32.98 - $35.16 $5.15 Million - $5.49 Million	156,173 Added 433813.88%	156,209 $0
Q2 2018 Aug 21, 2018	SELL	$32.98 - $35.16 $5.42 Million - $5.78 Million	-164,465 Reduced 99.98%	36 $156,000
Q1 2018 Apr 06, 2018	SELL	$31.91 - $37.02 $998,783 - $1.16 Million	-31,300 Reduced 15.99%	164,501 $5.84 Million
Q4 2017 Jan 10, 2018	SELL	$33.26 - $35.29 $222,842 - $236,443	-6,700 Reduced 3.31%	195,801 $7.09 Million
Q3 2017 Oct 12, 2017	BUY	$31.0 - $34.15 $6.28 Million - $6.92 Million	202,501	202,501 $7.23 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Waverton Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Waverton Investment Management LTD with notifications on news.

Account

Waverton Investment Management LTD Pfizer Inc Transaction History